Turning point therapeutics, inc. (TPTX)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18
Assets
Current assets:
Cash and cash equivalents

29,838

48,188

172,421

78,781

90,011

101,029

Marketable securities

350,944

360,963

251,154

171,389

-

-

Prepaid and other current assets

8,614

5,796

5,795

4,998

1,348

494

Total current assets

389,396

414,947

429,370

255,168

91,359

101,523

Property and equipment, net

2,661

2,689

2,184

954

958

1,000

Right-of-use lease assets

4,219

4,493

4,761

1,250

1,529

-

Deferred financing costs

-

-

-

-

1,579

684

Security deposits

73

73

73

73

73

73

Total assets

396,349

422,202

436,388

257,445

95,498

103,280

Liabilities and stockholders’ equity
Liabilities:
Current liabilities:
Accounts payable

1,846

2,150

3,811

4,086

2,697

1,494

Accrued expenses and other current liabilities

5,256

3,910

2,950

1,992

3,968

2,415

Accrued compensation

2,778

6,736

3,784

1,672

814

1,413

Current portion of operating lease liabilities

1,275

1,236

1,175

138

643

-

Total current liabilities

11,155

14,032

11,720

7,888

8,122

5,322

Deferred rent

-

-

-

-

-

448

Other long-term liabilities

-

-

-

260

-

-

Operating lease liabilities, long-term

3,487

3,819

4,144

1,382

1,465

-

Convertible preferred stock, $0.0001 par value; zero and 65,423,901 shares authorized, issued and outstanding at December 31, 2019 and December 31, 2018, respectively; aggregate liquidation preference of $0 and $146,460 at December 31, 2019 and December 31, 2018, respectively

-

-

-

-

145,916

145,916

Stockholders’ equity:
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019, respectively; 35,922,248 and 35,915,119 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

4

4

4

34

1

1

Additional paid-in capital

565,350

526,960

522,123

328,978

4,294

2,346

Accumulated other comprehensive (loss) income

-45

271

322

345

-

-

Accumulated deficit

-183,602

-122,884

-101,925

-81,442

-64,300

-50,753

Total stockholders' equity

381,707

404,351

420,524

247,915

-60,005

-48,406

Total liabilities and stockholders’ equity

396,349

422,202

436,388

257,445

95,498

103,280